Literature DB >> 11531407

Enhanced accumulation of coronavirus defective interfering RNA from expressed negative-strand transcripts by coexpressed positive-strand RNA transcripts.

S Banerjee1, J F Repass, S Makino.   

Abstract

Expression of negative-strand murine coronavirus mouse hepatitis virus (MHV) defective interfering (DI) RNA transcripts in MHV-infected cells results in the accumulation of positive-strand DI RNAs (M. Joo et al., 1996, J. Virol. 70, 5769-5776). However, the expressed negative-strand DI RNA transcripts are poor templates for positive-strand DI RNA synthesis. The present study demonstrated that DI RNA accumulation from the expressed negative-strand DI RNA transcripts in MHV-infected cells was enhanced by the coexpression of complementary RNA transcripts that correspond to the 5' region of positive-strand DI RNA. The positive-strand RNA transcripts corresponding to the 5' end-most 0.7-2.0 kb DI RNA had a similar enhancement effect. The coexpressed positive-strand RNA transcripts lacking the leader sequence or those containing only the leader sequence failed to demonstrate this enhancement effect, demonstrating that the presence of the leader sequence in the coexpressed positive-strand RNA transcripts was necessary, but not sufficient, for the enhancement of DI RNA accumulation from the coexpressed negative-strand DI RNA transcripts. Negative-strand DI RNA transcripts that were coexpressed with the partial-length positive-strand RNA transcripts were no more stable than those expressed alone, suggesting that a higher stability of the expressed negative-strand RNA transcripts was an unlikely reason for the higher DI RNA accumulation in cells coexpressing two complementary DI RNA transcripts. Sequence analyses unexpectedly demonstrated that the leader sequence of the majority of accumulated DI RNAs switched to helper virus derived leader sequence, suggesting that enhancement of DI RNA accumulation was mediated by the efficient utilization of helper virus derived leader sequence for DI RNA synthesis. Furthermore, our data suggested that this leader switching, a type of homologous RNA-RNA recombination, occurred during positive-strand DI RNA synthesis and that MHV positive-strand RNA synthesis mechanism may have a preference toward recognizing double-stranded RNA structures over single-stranded negative-strand RNA to produce positive-strand DI RNAs. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531407      PMCID: PMC7133719          DOI: 10.1006/viro.2001.1047

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations.

Authors:  R J de Groot; R G van der Most; W J Spaan
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs.

Authors:  R G van der Most; P J Bredenbeek; W J Spaan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 3.  RNA recombination in animal and plant viruses.

Authors:  M M Lai
Journal:  Microbiol Rev       Date:  1992-03

4.  Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis.

Authors:  S G Sawicki; D L Sawicki
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  Identification and characterization of a coronavirus packaging signal.

Authors:  J A Fosmire; K Hwang; S Makino
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

6.  Importance of the positive-strand RNA secondary structure of a murine coronavirus defective interfering RNA internal replication signal in positive-strand RNA synthesis.

Authors:  J F Repass; S Makino
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain.

Authors:  S Makino; F Taguchi; N Hirano; K Fujiwara
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

8.  Evolution of the 5'-end of genomic RNA of murine coronaviruses during passages in vitro.

Authors:  S Makino; M M Lai
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

9.  The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase.

Authors:  H J Lee; C K Shieh; A E Gorbalenya; E V Koonin; N La Monica; J Tuler; A Bagdzhadzhyan; M M Lai
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

10.  The virus-specific intracellular RNA species of two murine coronaviruses: MHV-a59 and MHV-JHM.

Authors:  J L Leibowitz; K C Wilhelmsen; C W Bond
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

View more
  3 in total

1.  Oligonucleotide Capture Sequencing of the SARS-CoV-2 Genome and Subgenomic Fragments from COVID-19 Individuals.

Authors:  Harshavardhan Doddapaneni; Sara Javornik Cregeen; Richard Sucgang; Qingchang Meng; Xiang Qin; Vasanthi Avadhanula; Hsu Chao; Vipin Menon; Erin Nicholson; David Henke; Felipe-Andres Piedra; Anubama Rajan; Zeineen Momin; Kavya Kottapalli; Kristi L Hoffman; Fritz J Sedlazeck; Ginger Metcalf; Pedro A Piedra; Donna M Muzny; Joseph F Petrosino; Richard A Gibbs
Journal:  bioRxiv       Date:  2020-12-11

2.  Infecting kidney organoids with a cDNA reporter clone of SARS-CoV-2.

Authors:  Hyunjae Chung; Maxwell P Bui-Marinos; Waleed Rahmani; Jennifer A Corcoran; Justin Chun
Journal:  STAR Protoc       Date:  2022-07-21

3.  Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.

Authors:  Elizabeth Jaworski; Rose M Langsjoen; Brooke Mitchell; Barbara Judy; Patrick Newman; Jessica A Plante; Kenneth S Plante; Aaron L Miller; Yiyang Zhou; Daniele Swetnam; Stephanea Sotcheff; Victoria Morris; Nehad Saada; Rafael Rg Machado; Allan McConnell; Steven G Widen; Jill Thompson; Jianli Dong; Ping Ren; Rick B Pyles; Thomas G Ksiazek; Vineet D Menachery; Scott C Weaver; Andrew L Routh
Journal:  Elife       Date:  2021-09-28       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.